INTRODUCTION: We evaluate the technical feasibility of robotic prostatectomy in renal transplant recipients. METHODS: We retrospectively analyzed preoperative and perioperative settings, as well as functional and oncologic results of 12 patients operated on between 2009 and 2013. Prostatectomy was performed via a transperitoneal approach without any changing in the ports position. The average age was 61.92 ± 2.98 years. The period between transplant and the diagnosis of adenocarcinoma was 79.7 months. The mean PSA was 7.34 ng/mL (range: 4.9-11). RESULTS: The operative time was 241.3 ± 35.6 minutes with only one conversion and one transfusion. The intervention was difficult due to adhesions on the side of the graft in 50% of cases. There was a case of obstructive acute renal failure resulting from a hematoma of the Retzius treated by percutaneous nephrostomy at D20. There was a majority of pT2c (72.7%), including 3 positive margins (27.3%) and 2 biochemical relapses treated with radiotherapy and hormonotherapy, respectively. The end point prostate-specific antigen was undetectable. There was no significant difference between preoperative and J7 creatinine (p = 0. 22). CONCLUSIONS: Robotic prostatectomy in renal transplant recipients is a safe technique with no serious effects on the allograft.
INTRODUCTION: We evaluate the technical feasibility of robotic prostatectomy in renal transplant recipients. METHODS: We retrospectively analyzed preoperative and perioperative settings, as well as functional and oncologic results of 12 patients operated on between 2009 and 2013. Prostatectomy was performed via a transperitoneal approach without any changing in the ports position. The average age was 61.92 ± 2.98 years. The period between transplant and the diagnosis of adenocarcinoma was 79.7 months. The mean PSA was 7.34 ng/mL (range: 4.9-11). RESULTS: The operative time was 241.3 ± 35.6 minutes with only one conversion and one transfusion. The intervention was difficult due to adhesions on the side of the graft in 50% of cases. There was a case of obstructive acute renal failure resulting from a hematoma of the Retzius treated by percutaneous nephrostomy at D20. There was a majority of pT2c (72.7%), including 3 positive margins (27.3%) and 2 biochemical relapses treated with radiotherapy and hormonotherapy, respectively. The end point prostate-specific antigen was undetectable. There was no significant difference between preoperative and J7 creatinine (p = 0. 22). CONCLUSIONS: Robotic prostatectomy in renal transplant recipients is a safe technique with no serious effects on the allograft.
Authors: M Raschid Hoda; Amir Hamza; Francesco Greco; Sigrid Wagner; Olaf Reichelt; Hans Heynemann; Kersten Fischer; Paolo Fornara Journal: Nephrol Dial Transplant Date: 2010-04-12 Impact factor: 5.992
Authors: R Houston Thompson; Bradley C Leibovich; R Jeffrey Karnes; Eric J Bergstralh; Michael L Blute Journal: J Urol Date: 2008-03-04 Impact factor: 7.450
Authors: François M Kleinclauss; Yann Neuzillet; Xavier Tillou; Nicolas Terrier; Guillaume Guichard; Jacques Petit; Eric Lechevallier Journal: Urology Date: 2008-04-24 Impact factor: 2.649
Authors: Mario Alvarez Maestro; Angel Tabernero Gómez; Sergio Alonso Y Gregorio; Jesús Cisneros Ledo; Javier de la Peña Barthel; Luis Martínez-Piñeiro Journal: BJU Int Date: 2009-10-05 Impact factor: 5.588
Authors: Mohammed Shahait; Fawaz Al Majali; Ryan W Dobbs; Alex Sandberg; Adnan El-Achkar; Ayah El-Fahmawi; Philip Mucksavage; David I Lee Journal: JSLS Date: 2021 Jul-Sep Impact factor: 2.172
Authors: Juan Manuel Ochoa-López; Bernardo Gabilondo-Pliego; Sylvain Collura-Merlier; Jaime O Herrera-Cáceres; Mariano Sotomayor de Zavaleta; Francisco Tomás Rodríguez-Covarrubias; Guillermo Feria-Bernal; Fernando Gabilondo-Navarro; Ricardo Alonso Castillejos-Molina Journal: Int Braz J Urol Date: 2018 Sep-Oct Impact factor: 1.541